Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients
Clinical trial NCT01663116 · COMPLETED
Trial details
- NCT number
- NCT01663116
- Sponsor
- Tigenix S.A.U.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-01-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.